Receive our newsletter – data, insights and analysis delivered to you
June 3, 2009

PolyMedix to Research Anti-Biowarfare Pathogens

PolyMedix has received a research contract worth $1.6m from the US Defense Threat Reduction Agency (DTRA), to develop more effective rapid-response counter-measures to combat biowarfare bacterial pathogens. The goal of the contract is to devise new defensin-mimetic antibiotic compounds to

By cms admin

PolyMedix has received a research contract worth $1.6m from the US Defense Threat Reduction Agency (DTRA), to develop more effective rapid-response counter-measures to combat biowarfare bacterial pathogens.

The goal of the contract is to devise new defensin-mimetic antibiotic compounds to provide more effective rapid-response countermeasures against biowarfare bacterial pathogens and other public health threats.

PolyMedix president and CEO Nicholas Landekic said that the company appreciated the DTRA’s interest in the PolyMedix novel antibiotic approach.

“Safeguarding public safety against these dangerous infectious threats is a critically important goal,” Landekic said.

The work will be conducted by PolyMedix, which will include preclinical animal efficacy studies for intravenous defensin-mimetic antibiotic agents against Category A and B biopathogens, including the infectious agents that cause anthrax, plague and tularemia.

Content from our partners
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide
Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU